These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7276637)
1. Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. Martin RR; Couch RB; Greenberg SB; Cate TR; Warr GA J Infect Dis; 1981 Sep; 144(3):279-80. PubMed ID: 7276637 [No Abstract] [Full Text] [Related]
2. The effect of immunization on polymorphonuclear leukocyte chemotaxis in influenza. Baum J; Douglas RG Acta Virol; 1979 Sep; 23(5):433-6. PubMed ID: 42304 [TBL] [Abstract][Full Text] [Related]
5. The influenza virus--infected phagocyte. A model of deactivation. Hartshorn KL; Tauber AI Hematol Oncol Clin North Am; 1988 Jun; 2(2):301-15. PubMed ID: 2455702 [TBL] [Abstract][Full Text] [Related]
6. Influenza virus split vaccines. Effect of priming infection on serologic response in humans. Niculescu IT; Zilisteanu E; Cretescu L; Matepiuc M; Dumitrescu R; Oprescu E; Bodnar C; Cuteanu I; Vlad A; Mogos A Arch Roum Pathol Exp Microbiol; 1979; 38(2):147-54. PubMed ID: 262510 [No Abstract] [Full Text] [Related]
7. Lack of parallelism in antibody responses as measured by enzyme immunoassay after infection due to influenza virus A/USSR/77 (H1N1). Hammond GW; Noble GR; Smith SJ J Infect Dis; 1982 Dec; 146(6):827. PubMed ID: 7142752 [No Abstract] [Full Text] [Related]
8. Role of serum in stimulation of polymorphonuclear leukocyte, luminol-dependent chemiluminescence by influenza A. Shult PA; Dick EC; Joiner KA; Busse WW Am Rev Respir Dis; 1985 Feb; 131(2):267-72. PubMed ID: 3970456 [TBL] [Abstract][Full Text] [Related]
9. The effect of influenza virus on human polymorphonuclear leukocytes. Debets-Ossenkopp Y; van Dijk WC; Mills EL; Verbrugh HA; Verhoef J Antonie Van Leeuwenhoek; 1980; 46(1):103. PubMed ID: 7396475 [No Abstract] [Full Text] [Related]
10. [How the human body protects itself against the influenza virus]. Shvartsman IaS Med Sestra; 1984 Mar; 43(3):13-6. PubMed ID: 6562340 [No Abstract] [Full Text] [Related]
12. Appearance of influenza A virus antigenic variants after treatment of infected MDCK cells with human leukocytes. Murakami T; Matsuyama T J Gen Virol; 1988 Aug; 69 ( Pt 8)():1841-5. PubMed ID: 3404115 [TBL] [Abstract][Full Text] [Related]
13. Immunity status against influenza A subtype H7N9 and other avian influenza viruses in a high-risk group and the general population in India. Pawar SD; Tandale BV; Gurav YK; Parkhi YK; Kode SS J Infect Dis; 2014 Jul; 210(1):160-1. PubMed ID: 24453261 [No Abstract] [Full Text] [Related]
14. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination]. Stumpa A; Tůmová B Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986 [No Abstract] [Full Text] [Related]
15. How does influenza virus pave the way for bacteria? Lancet; 1982 Feb; 1(8270):485-6. PubMed ID: 6174835 [No Abstract] [Full Text] [Related]
16. Human responses to experimental infection with influenza A/Equi 2 virus. Alford RH; Kasel JA; Lehrich JR; Knight V Am J Epidemiol; 1967 Jul; 86(1):185-92. PubMed ID: 4951557 [No Abstract] [Full Text] [Related]
19. Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells. Gotoff R; Tamura M; Janus J; Thompson J; Wright P; Ennis FA J Infect Dis; 1994 Jan; 169(1):200-3. PubMed ID: 8277183 [TBL] [Abstract][Full Text] [Related]
20. The hamster as a model for the study of immunity to influenza virus infection. Jennings R; Potter CW Fed Proc; 1978 May; 37(7):2072-3. PubMed ID: 640018 [No Abstract] [Full Text] [Related] [Next] [New Search]